104
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the miR-194-5p/YAP Axis

, , , , &
Pages 3171-3180 | Published online: 12 Apr 2021

References

  • Lopes RI, Lorenzo A. Recent advances in the management of Wilms’ tumor. F1000Res. 2017;6:670. doi:10.12688/f1000research.10760.128620463
  • Bhatnagar S. Management of Wilms’ tumor: NWTS vs SIOP. J Indian Assoc Pediatr Surg. 2009;14(1):6–14. doi:10.4103/0971-9261.5481120177436
  • Brok J, Lopez-Yurda M, Tinteren HV, et al. Relapse of Wilms’ tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms’ tumour protocol database. Lancet Oncol. 2018;19(8):1072–1081. doi:10.1016/S1470-2045(18)30293-629960848
  • Martínez CH, Dave S, Izawa J. Wilms’ tumor. Adv Exp Med Biol. 2010;685:196–209.20687507
  • Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005;23(29):7312–7321. doi:10.1200/JCO.2005.01.279916129848
  • Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641. doi:10.1016/j.cell.2009.02.00619239885
  • Li S, Lin A, Han D, et al. LINC00673 rs11655237 C>T and susceptibility to Wilms tumor: a five-center case-control study. J Gene Med. 2019;21(12):e3133. doi:10.1002/jgm.313331657076
  • Zhuo Z, Fu W, Liu J, et al. LIN28A gene polymorphisms confer Wilms tumour susceptibility: a four-centre case-control study. J Cell Mol Med. 2019;23(10):7105–7110. doi:10.1111/jcmm.1456131338973
  • Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914. doi:10.1016/j.molcel.2011.08.01821925379
  • Chang S, Chen B, Wang X, Wu K, Sun Y. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression. BMC Cancer. 2017;17(1):248. doi:10.1186/s12885-017-3216-628388883
  • Ma L, Zhou Y, Luo X, Gao H, Deng X, Jiang Y. Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer. Oncotarget. 2017;8(3):4125–4135. doi:10.18632/oncotarget.1367027911852
  • Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.01421802130
  • Zhang P, Li J, Song Y, Wang X. MiR-129-5p inhibits proliferation and invasion of chondrosarcoma cells by regulating SOX4/Wnt/β-catenin signaling pathway. Cell Physiol Biochem. 2017;42(1):242–253. doi:10.1159/00047732328535514
  • Liu H, Ren SY, Qu Y, et al. MiR-194-5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk. Kaohsiung J Med Sci. 2020;36(4):265–273. doi:10.1002/kjm2.1218031889432
  • Ahmed AA, Mohamed AD, Gener M, Li W, Taboada E. YAP and the Hippo pathway in pediatric cancer. Mol Cell Oncol. 2017;4(3):e1295127. doi:10.1080/23723556.2017.129512728616573
  • Kann M, Ettou S, Jung YL, et al. Genome-wide analysis of Wilms’ tumor 1-controlled gene expression in podocytes reveals key regulatory mechanisms. J Am Soc Nephrol. 2015;26(9):2097–2104. doi:10.1681/ASN.201409094025636411
  • Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981. doi:10.1158/0008-5472.CAN-16-263428701486
  • Yin S, Dou J, Yang G, Chen F. Long non-coding RNA XIST expression as a prognostic factor in human cancers: a meta-analysis. Int J Biol Markers. 2019;34(4):327–333. doi:10.1177/172460081987301031566056
  • Tian K, Sun D, Chen M, et al. Long noncoding RNA X-inactive specific transcript facilitates cellular functions in melanoma via miR-139-5p/ROCK1 pathway. Onco Targets Ther. 2020;13:(1277–1287. doi:10.2147/OTT.S225661
  • Luo C, Quan Z, Zhong B, et al. lncRNA XIST promotes glioma proliferation and metastasis through miR-133a/SOX4. Exp Ther Med. 2020;19(3):1641–1648. doi:10.3892/etm.2020.842632104215
  • Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65(6):1140–1151. doi:10.1016/j.eururo.2013.12.00324373479
  • Song MA, Park JH, Jeong KS, Park DS, Kang MS, Lee S. Quantification of CpG methylation at the 5ʹ-region of XIST by pyrosequencing from human serum. Electrophoresis. 2007;28(14):2379–2384. doi:10.1002/elps.20060085217578842
  • Zheng H, Li BH, Liu C, Jia L, Liu FT. Comprehensive analysis of lncRNA-mediated ceRNA crosstalk and identification of prognostic biomarkers in Wilms’ tumor. Biomed Res Int. 2020;2020:4951692.32149111
  • Jung DE, Park SB, Kim K, Kim C, Song SY. CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway. Sci Rep. 2017;7(1):10921. doi:10.1038/s41598-017-11094-328883618